Aktuellt
SENASTE
Redeye returns with a more detailed take on Sedana Medical’s Q1 report, and we see signs of improved operational development. Sales and OPEX surprised us positively, though we argue that there still are some obstacles to manoeuvre until the company can continue its growth journey full steam ahead.
LÄS MER
